Intellia Therapeutics Logo Vector
View other drafts
Intellia Therapeutics is a clinical-stage biotechnology company pioneering novel, potentially curative therapeutics leveraging CRISPR-based gene editing technologies. The company’s mission is to transform the lives of patients with severe diseases by developing truly transformative treatment options. Intellia is advancing a broad pipeline of in vivo and ex vivo CRISPR-based therapies for a range of diseases, including transthyretin amyloidosis, sickle cell disease, and cancer.
